| Date | Time | Source | |
| 02/14/2013 | 2:00AM | RNSNON | Cyprotex PLC Launch of new cardiotoxicity service-eCiphrCardio
TIDMCRX RNS Number : 8385X Cyprotex PLC 14 February 2013 Cyprotex launches a new cardiotoxicity service - eCiphrCardio 14 February, 2013 - Cyprotex PLC (AIM:CRX), the specialist preclinical contract research organisation (CRO), today announces the launch of eCiphrCardio, an assay to assess potential cardiotoxicity of compounds... More...>> |
| 10/30/2012 | 11:28AM | DJN | Cyprotex in Collaborative Research Agreement with Pfizer
LONDON--Cyprotex PLC (CRX.LN), the preclinical ADME-Tox services company, Tuesday announced a collaborative research agreement between its wholly owned subsidiary Apredica LLC and Pfizer Inc. (PFE). MAIN FACTS: -No financial details have been disclosed -The deal extends over an eighteen month period and is split into two... More...>> |
| 08/02/2012 | 2:01AM | RNSNON | Cyprotex PLC Updated Regulatory Guidance Booklet
TIDMCRX RNS Number : 1102J Cyprotex PLC 02 August 2012 2(nd) August 2012 Cyprotex PLC Cyprotex launch their updated Drug-Drug Interaction Regulatory Guidance booklet to reflect the new FDA and EMA guidelines Cyprotex PLC (AIM:CRX), the ADME Tox specialists, have today launched an update of their popular Drug-Drug Interaction... More...>> |
| 06/21/2012 | 2:00AM | RNSNON | Alliance with Sirius Analytical
TIDMCRX RNS Number : 8267F Cyprotex PLC 21 June 2012 Cyprotex PLC Cyprotex strengthen physicochemical profiling services in alliance with Sirius Analytical 21 June, 2012 - Cyprotex PLC (AIM:CRX), the preclinical ADME-Tox services company, and Sirius Analytical Instruments Ltd, leaders in physiochemical profiling, today... More...>> |
| 10/04/2011 | 2:00AM | RNSNON | Launch of New Genomic ADME Service
TIDMCRX RNS Number : 4915P Cyprotex PLC 04 October 2011 4 October 2011 Cyprotex Launches Breakthrough Genomic ADME Service (gADME(TM) ) New Service Provides Understanding of Genetic Variations on Drug Response Cyprotex PLC (AIM:CRX), the preclinical ADME-Tox services company, today announces the launch of its new Genomic... More...>> |
| 09/27/2011 | 2:01AM | RNSNON | Product Launch
TIDMCRX RNS Number : 9631O Cyprotex PLC 27 September 2011 27 September 2011 Cyprotex Adds High Content Screening In Vitro Micronucleus Test High Content Screening Approach Improves Early Genotoxicity Detection Cyprotex PLC(LSE:CRX), the preclinical ADME Tox services company, today announces that it has added to its service... More...>> |
| 06/09/2011 | 5:00AM | RNSNON | Pharmaceutical Safety Testing Open Letter
TIDMCRX RNS Number : 1180I Cyprotex PLC 09 June 2011 Cyprotex PLC ("Cyprotex" or the "Company" or the "Group") Concerns About Pharmaceutical Safety Testing Cause Cyprotex to Join in Signing an Open Letter to Prime Minister David Cameron and Health Secretary Andrew Lansley On behalf of Cyprotex PLC (AIM:CRX), Dr. Katya... More...>> |
| 03/23/2011 | 1:26PM | DJN | UPDATE: UK Government Budget Gives Boost To Big Pharma, Biotechs
The U.K. life sciences sector got a boost Wednesday when the British government backed a number of industry demands designed to stimulate drug research. U.K. Chancellor of the Exchequer George Osborne told lawmakers the government will boost tax relief for research and development carried out by small and medium-sized... More...>> |
| 12/07/2010 | 3:00AM | PRNUS | CellCiphr(TM) Toxicity Panels Revalidated by Cyprotex
CellCiphr(TM) Toxicity Panels Revalidated by Cyprotex PR Newswire MACCLESFIELD, England, December 7, 2010 MACCLESFIELD, England, December 7, 2010 /PRNewswire/ -- Cyprotex (LSE:CRX), the preclinical ADME Tox services company, announces the successful cross validation of the CellCiphr(TM) cytotoxicity panels and their official... More...>> |
| 12/01/2010 | 2:00AM | RNSNON | Relaunch of Cellumen Products
TIDMCRX RNS Number : 1196X Cyprotex PLC 01 December 2010 ? 1st December 2010 Cyprotex PLC ("Cyprotex" or the "Company") CellCiphrTM Toxicity Panels Revalidated by Cyprotex Cyprotex (LSE:CRX), the preclinical ADME Tox services company, announces the successful cross validation of the CellCiphrTM cytotoxicity panels and... More...>> |
| 10/19/2010 | 5:07AM | RNSNON | Product Update
TIDMCRX RNS Number : 6156U Cyprotex PLC 19 October 2010 19th October, 2010 Cyprotex Extends Time Dependent Inhibition Service to Include the Cytochrome P450 Isoform, CYP2B6 Cyprotex PLC (LSE:CRX), the preclinical ADME Tox services company, today announces that it has extended its time-dependent inhibition service to include... More...>> |
| 10/12/2010 | 4:37AM | RNSNON | Launches new transporter assay for BCRP
TIDMCRX RNS Number : 2355U Cyprotex PLC 12 October 2010 ? Cyprotex launches new transporter assay to investigate BCRP interactions Cyprotex announces that it has introduced a new transporter assay service to assess BCRP (breast cancer resistance protein; ABCG2) interactions. This new assay extends Cyprotex's existing range... More...>> |
| 10/01/2010 | 2:00AM | RNSNON | Cyprotex officially open new toxicology laboratory
TIDMCRX RNS Number : 6790T Cyprotex PLC 01 October 2010 ? Cyprotex officially open new toxicology laboratory Today, David Rutley, MP for Macclesfield, will officially open Cyprotex's new toxicology facility at its headquarters in Macclesfield, UK. The additional 90 square metres of laboratory space houses the very latest... More...>> |
| 09/16/2010 | 2:00AM | RNSNON | Cyprotex and TB Alliance form collaboration
TIDMCRX RNS Number : 7847S Cyprotex PLC 16 September 2010 ? Cyprotex PLC ("Cyprotex" or "the Company") Cyprotex and TB Alliance form collaboration to aid the struggle against global tuberculosis (TB) Cyprotex have been selected by The Global Alliance for TB Drug Development (TB Alliance) to work with the Alliance in the... More...>> |
| 09/01/2010 | 2:00AM | RNSNON | Provides free online access to Cloe Knowledge
TIDMCRX RNS Number : 9275R Cyprotex PLC 01 September 2010 ? 1 September 2010 Cyprotex PLC ("Cyprotex" or "the Company") Cyprotex Announces Free Access to Physicochemical, ADME, and Pharmacokinetic Data of Marketed Drugs Through Its Visualisation Tool, Cloe Knowledge Cyprotex PLC (LSE:CRX), the preclinical ADME Tox services... More...>> |
| 08/20/2010 | 2:00AM | RNSNON | Cyprotex Adds In Vitro Toxicology Services
TIDMCRX RNS Number : 3662R Cyprotex PLC 20 August 2010 ? 20 August 2010 Cyprotex PLC ("Cyprotex" or "the Company") Cyprotex Adds In Vitro Toxicology Services Cyprotex PLC (LSE:CRX), the preclinical ADME Tox services company, today announces the launch of its new in vitro toxicology service, branded as Cyprotox . Supporting... More...>> |
| 08/20/2010 | 1:15AM | PRNUS | Cyprotex Adds In Vitro Toxicology Services
Cyprotex Adds In Vitro Toxicology Services PR Newswire MACCLESFIELD, England, August 20, 2010 MACCLESFIELD, England, August 20, 2010 /PRNewswire/ -- Cyprotex PLC (LSE:CRX), the preclinical ADME Tox services company, today announces the launch of its new in vitro toxicology service, branded as Cyprotox(R). Supporting the... More...>> |
